Skip to main content

JPMORGAN CHASE & CO

Position in TBPH — Theravance Biopharma, Inc.

CIK 19617 NEW YORK, NY

Position in TBPH

as of Mar 31, 2026 · filed May 13, 2026
Position Value
$2,065,540
-$5,725,452 QoQ
Shares Held
127,267
-69.4% QoQ
Ownership
0.247%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 86% Shared 0% None 14%

Common Shares in TBPH Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

JPMORGAN CHASE & CO holds $15,763,119,646 across 407 Biotechnology names. TBPH ranks #134 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in TBPH

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $2,065,540 127,267
2025-12-31 $7,790,992 416,408
2025-09-30 $3,111,316 213,104
2025-06-30 $1,318,225 119,513
2025-03-31 $1,400,372 156,817
2024-12-31 $2,066,132 219,568
2024-09-30 $2,151,042 266,879
2024-06-30 $2,198,514 259,259
2024-03-31 $276,839 30,863
2023-12-31 $495,559 44,089
2023-09-30 $411,736 47,710
2023-06-30 $526,442 50,864
2023-03-31 $2,305,917 212,527
2022-12-31 $2,399 213,848
2022-09-30 $2,029,144 200,113
2022-06-30 $1,878,635 207,355
2022-03-31 $1,656,670 173,292
2021-12-31 $2,266,464 205,110
2021-09-30 $1,726,188 233,269
2021-06-30 $514,703 35,448
2021-03-31 $586,827 28,752
2020-12-31 $648,870 36,515
2020-09-30 $253,518 17,147
2020-06-30 $326,100 15,536
2020-03-31 $366,107 15,842